Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2493 (LINC02493) is a lincRNA, meaning it is a long non-coding RNA transcript located between protein-coding genes that does not itself encode a protein[1][3]. LincRNAs like LINC02493 are longer than 200 nucleotides and generally act as regulators of gene expression through mechanisms such as chromatin remodeling, transcriptional regulation, and modulation of RNA stability[3][5]. While lincRNAs as a class have been implicated in various biological processes and diseases, including cancer, there is currently no direct evidence for LINC02493 serving as a therapeutic target, as a biomarker, or as having known drug interactions[1][3]. Its precise functional roles and disease associations remain to be established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2493 (LINC02493).